Sumanta (Monty) Kumar Pal, M.D. Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research Co-director, Kidney Cancer Program, Medical Oncologist, shares thoughts on Nivolumab + Ipilimumab at the 2018 Oncology Summit in Huntington Beach, CA
Go to: http://www.moasc.org for more information
Advertisement